Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.
about
Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trialFuture paradigms for precision oncologyMulti-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data.Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies.Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial.Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.New generation of breast cancer clinical trials implementing molecular profiling.Clinical Outcomes of Patients with Rare and Heavily Pretreated Solid Tumors Treated according to the Results of Tumor Molecular Profiling.Highlights from the 2016 WIN Symposium, 27-29 June 2016, Paris: personalised therapy beyond next-generation sequencingNew strategies in personalized medicine for solid tumors: molecular markers and clinical trial designs.Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic.Implementing personalized cancer genomics in clinical trials.Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test.Patient-centric trials for therapeutic development in precision oncology.Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.Physician Experiences and Understanding of Genomic Sequencing in Oncology.Clinical trials for precision oncology using next-generation sequencing.Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.
P2860
Q27015838-2B2EE96F-0BC0-467A-9391-96FB15A56E76Q28078745-4BB616D2-5F9C-4D38-8377-48D2DEA3A864Q30836209-1C8B9D72-A0AC-4522-B2F0-93E1A8EBA80CQ33686447-629F660C-66C4-4B67-8317-0114982B31A1Q33877385-13BF9CEE-1D1D-476C-928F-A595CCD6BA6CQ36303802-79331F4D-468B-410F-AF7B-A91CADF56B73Q37094064-398BDA3B-F861-4951-888C-1B5F273F9A9EQ37150582-D8BCAED2-6699-436F-AB17-1E45508C475AQ37239007-713411A9-634B-4E7C-976F-B9EB834DC873Q37724947-8C61E8A6-533A-49ED-984C-5DD8CAA085CDQ37726365-3CE64305-56ED-4163-A52F-903156F0A675Q38102920-14187F75-CBF5-43C7-923A-C011BC8DAD35Q38235827-09C1D52E-803F-4DDF-B3CB-452BDFB8610AQ38607709-C0DA9741-D009-4BB7-ABF6-3EB160F95F1AQ43500764-D91CE8DB-5615-4158-A2D1-7C49EC1454D7Q47726388-79382FDA-E3E9-47A6-9D5A-AB6041B3ED59Q54257611-3D89A4C3-F65D-413E-9758-BA937271342AQ55458851-B565CAA3-FCF0-4D14-9A3D-13E22EE54211
P2860
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Designs and challenges for per ...... ogy: focus on the SHIVA trial.
@en
type
label
Designs and challenges for per ...... ogy: focus on the SHIVA trial.
@en
prefLabel
Designs and challenges for per ...... ogy: focus on the SHIVA trial.
@en
P2093
P2860
P50
P1433
P1476
Designs and challenges for per ...... logy: focus on the SHIVA trial
@en
P2093
Anne Vincent-Salomon
Anne-Lise Pouliquen
Anthony Goncalves
Christophe Le Tourneau
David Gentien
Jean-Pierre Delord
Mario Campone
Maud Kamal
Nicolas Isambert
Sébastien Armanet
P2860
P2888
P304
P356
10.1007/S11523-012-0237-6
P577
2012-11-17T00:00:00Z
P5875
P6179
1018978491